Britain will have to pay nearly £2,000-per-patient for Covid-19 drug
Britain will have to pay almost £2,000-per-patient for one of the only two approved Covid-19 drugs, it was revealed today. Gilead Sciences announced it would charge governments of developed countries $390 (£320) per vial of remdesivir. Most hospitalised patients will need six vials of the Ebola drug — equating to $2,340 (£1,900) for every patient, … Read more